Avalon GloboCare Appoints Lourdes Felix, CEO of a Premier Addiction Treatment Company, to its Board of Directors Jan 11, 2023 09:00AM
BioCorRx and 2B3D to Pilot First-of-its-Kind PTSD and Addiction Treatment Solutions for Veterans in Metaverse Setting May 19, 2022 08:00AM
BioCorRx, Inc. Announces Launch of Pilot Program with Louisiana Department of Corrections for Offenders Suffering with Alcohol and Opioid Use Disorders May 2, 2019 08:00AM
BioCorRx’s Subsidiary, BioCorRx Pharmaceuticals, to Exhibit at ASAM 50th Annual Conference in Orlando, Florida Mar 28, 2019 08:00AM
BioCorRx Promotes Dr. Balbir S. Brar to Senior VP of Drug Development; Extends Service Agreement Mar 27, 2019 07:37AM


Mar 14, 2019 08:00AM BioCorRx to Present at the 31st Annual ROTH Conference on March 17-19, 2019
Feb 26, 2019 08:00AM BioCorRx Partners with IRISYS for Manufacturing of BICX102 Naltrexone Implant for Treatment of Opioid Use Disorder
Feb 25, 2019 08:00AM BioCorRx Appoints Two Finance Veterans to the Board of Directors
Feb 19, 2019 10:26AM BioCorRx Announces Formation of Scientific Advisory Board
Jan 22, 2018 10:54AM CORRECTION: CEO, Brady Granier, From BioCorRx® Inc. Discusses Upcoming FDA Meeting on “Stock Day” Podcast; Aims to Fight Opioid Crisis
Jan 22, 2018 07:00AM CEO, Brady Grainer, From BioCorRx®Inc. Paves Pathway Towards Possible FDA Approval on “Stock Day” Podcast; Aims to Fight Opioid Crisis